the aid library

Filter

4471

Third progress analysis of implementation of antimicrobial resistance national action plans in the WHO South-East Asia Region

World Health Organization WHO (2022) C_WHO

Antimicrobial resistance (AMR) is described as a situation when bacteria, viruses, fungi and parasites change over time and no longer respond to medicines, making infections harder or impossible to treat, and increasing the risk of disease spread, severe illness and death.1 AMR in recent years has ... more

Good Practices in strengthening health systems for the prevention and care of Tuberculosis and drug-resistant Tuberculosis (Russian edition)

World Health Organization, Europe Всемирная организация здравоохранения (2016) C_WHO

Примеры надлежащей практики в области укрепления систем здравоохранения с целью профилактики и лечения туберкулеза и лекарственно-устойчивого туберкулеза

Guidance to facilitate monitoring and evaluation for antimicrobial resistance national action plans

Quadripartite: Food and Agriculture Organization of the United Nations FAO; UN Environment Programme UNEP; World Health Organization WHO; World Organisation for Animal Health WAHO (2023) CC

Antimicrobial resistance (AMR) is a global human, animal, plant and environment health threat that needs to be addressed by every country. The impacts of AMR are wide-ranging in terms of human health, animal health, food security and safety, environmental effects on ecosystems and biodiversity, and ... socioeconomic development. Just like the climate crisis, AMR poses a significant threat to the delivery of the 2030 Agenda for Sustainable Development. The response to the AMR crisis has been spearheaded through the global action plan on antimicrobial resistance (GAP-AMR), developed by the World Health Organization (WHO) in 2015, in close collaboration with the Food and Agriculture Organization of the United Nations (FAO) and the World Organisation for Animal Health (WOAH), and formally endorsed by the three organizations’ governing bodies and by the Political Declaration of the high-level meeting of the United Nations General Assembly on AMR in 2016. In 2022, the three organizations officially became the Quadripartite by welcoming the United Nations Environment Programme (UNEP) into the alliance “to accelerate coordination strategy on human, animal and ecosystem health”. The aim of the GAP-AMR is to ensure the continuity of successful treatment with effective and safe medicines. Its strategic objectives include: • improving the awareness and understanding of AMR; • strengthening the knowledge and evidence base through surveillance and research; • reducing the incidence of infection through effective sanitation, hygiene and infection prevention measures; optimizing the use of antimicrobial medicines in human and animal health; and • developing the economic case for sustainable investment that takes account of the needs of all countries and increasing investment in new medicines, diagnostic tools, vaccines and other interventions. With the adoption of the GAP-AMR, countries agreed to develop national action plans (NAPs) aligned with the GAP-AMR to mainstream AMR interventions nationally. Individually, the Quadripartite took action to advance AMR interventions in their respective sectors. FAO adopted a resolution on AMR recognizing that it poses an increasingly serious threat to public health and sustainable food production, and developed an AMR action plan to support the resolution’s implementation. For its part, WOAH developed a strategy on AMR aligned with the GAP-AMR, acknowledging the importance of a One Health approach to AMR. Similarly, more recently, UNEP’s governing body, the United Nations Environment Assembly, recognized that AMR is a current and increasing threat and a challenge to global health, food security and the sustainable development of all countries, and welcomed the GAP-AMR and the NAPs developed in accordance with its five overarching strategic objectives more

Framework for the engagement of all health care providers in the management of drug resistant tuberculosis

World Health Organization (2015) C_WHO

The END TB strategy

Combined Use of Delamanid and Bedaquiline to Treat Multidrug-Resistant and Extensively Drug-Resistant Tuberculosis: A Systematic Review

G. B. Migliori, E. Pontali, G. Sotgiu, et al. International Journal of Molecular Scienes (2017) C2

Int. J. Mol. Sci. 2017, 18, 341, 1 - 10

An exploration of facilitators and challenges in the scale-up of a national, public sector community health worker cadre in Zambia: a qualitative study

S. Chauwa Phiri, M.Lippitt Prust, C. Phiri Chibawe, et al. (2017) CC

Phiri et al. Human Resources for Health (2017) 15:40 DOI 10.1186/s12960-017-0214-3

Living Conditions among People with Activity Limitations in Malawi. A National Representative Study.

ME Loeb, Arne H Eide SINTEF Health Research (2004) C1

This research report provides results from the study on living conditions among people with disabilities in Malawi. Comparisons are made between individuals with and without disabilities and also between households with and without a disabled family member. Results obtained in Malawi are also comp ... more

Cost and Outcomes of ART Scale-up in Zambia: Modelled estimates for test and treat & community based service delivery models. Policy brief

USAID, et al. (2016) C1

Patient-Planetary Health Co-benefit Prescribing: Emerging Considerations for Health Policy and Health Professional Practice

N. Redverse (2021) C1

Meeting report of the WHO expert consultation on the definition of extensively drug-resistant tuberculosis

World Health Organization WHO (2021) CC

Meeting Report 27-29 October 2020 The overall goal of the meeting was to discuss recent changes in treatment regimens and diagnostics for drug-resistant TB and to determine how these impact on the definition of XDR-TB, with a view to revising this ... more

Prioritization of pathogens to guide discovery, research and development of new antibiotics for drug-resistant bacterial infections, including tuberculosis

World Health Organization (2017) C_WHO

STANDARD OPERATING PROCEDURE (SOP) FOR INTRODUCTION OF PUBLIC HEALTH PESTICIDES INCLUDING BIOLARVICIDES IN THE NATIONAL VECTOR CONTROL PROGRAMME

Indian Council of Medical Research (ICMR); National Vector Borne Disease Control Programme (NVBDCP); National Centre for Disease Control (NCDC) (2014) C1

Implementation manual to prevent and control the spread of carbapenem-resistant organisms at the national and health care facility level
recommended

World Health Organization WHO (2020) C_WHO

This manual presents a compelling case for action on carbapenem-resistant organisms (CROs) and describes the linkages between the prevention and control of CROs and the Global Action Plan on Antimicrobial Resistance (AMR). It describes how the eight recommendations contained within the World Health ... more

Prevalence and factors associated with prediabetes and diabetes mellitus in Kenya: results from a national survey

Mohamed, S.F.; Mwangi M., Mutua1 M.K., et al. BMC Public Health (2018) C1

Mohamed et al. BMC Public Health 2018, 18(Suppl 3):1215 https://doi.org/10.1186/s12889-018-6053-xpre-

The use of loop-mediated isothermal amplification (TB-LAMP) for the diagnosis of pulmonary tuberculosis: policy guidance

World Health Organization WHO (2016) C_WHO

Following review of the latest evidence, WHO recommends that TB-LAMP can be used as a replacement for microscopy for the diagnosis of pulmonary TB in adults with signs and symptoms of TB. It can also be considered as a follow-on test to microscopy in adults with signs and symptoms of pulmonary TB, e ... more

TB Guidelines for Nurses in the Care and Control of Tuberculosis and Multi-drug Resistant Tuberculosis

International Council of Nurses (2015) C2

3rd edition.

Epilepsy care guidelines for low- and middle-income countries: From WHO mental health GAP to national programs

J. Katchanov; G. L. Birbeck BMC Medicine (2012) CC

BMC Medicine201210:107 https://doi.org/10.1186/1741-7015-10-107© Katchanov and Birbeck; licensee BioMed Central Ltd. 2012 Received: 10 July 2012Accepted: 24 September 2012Published: 24 September 2012 In 2011, the World Health Organization’s (WHO) mental health Gap Action Programme (mhGAP) r ... more

Essential health care service disruption due to COVID-19: lessons for sustainability in Nigeria

AHOP National Centre based in Nigeria World Health Organization WHO, Regional Office Africa (2022) C_WHO

The brief concludes that sustaining the continuity of EHS requires policies that ensure a whole-society and systems strengthening approach. This involves increased health care investment, community engagement, disease control regulations, and multisector approaches to improve resilience, EHS quality ... more

Women speak out: understanding women who inject drugs in Indonesia

Indonesian Drug Users Network (2016) C1